Company name Infosys Technologies Limited (ADR)
Stock ticker INFY
Live stock price [stckqut]INFY[/stckqut]
P/E compared to competitors Fair
MANAGEMENT EXECUTION
Employee productivity Poor
Sales growth Good
EPS growth Good
P/E growth Poor
EBIT growth Good
ANALYSIS
Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $93.39
Target stock price (averages with growth) $97.87
Target stock price (averages with no growth) $85.97
Target stock price (manual assumptions) $77.7

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in this stock as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns.

Company name Automatic Data Processing
Stock ticker ADP
Live stock price [stckqut]ADP[/stckqut]
P/E compared to competitors Fair
MANAGEMENT EXECUTION
Employee productivity Good
Sales growth Poor
EPS growth Good
P/E growth Poor
EBIT growth Poor
ANALYSIS
Confident Investor Rating Poor
Target stock price (TWCA growth scenario) $32.45
Target stock price (averages with growth) $39.38
Target stock price (averages with no growth) $38.38
Target stock price (manual assumptions) $44.33

Confident Investor comments: At this price and at this time, I do not think that a Confident Investor can confidently invest in this stock.

Company name priceline.com Incorporated
Stock ticker PCLN
Live stock price [stckqut]PCLN[/stckqut]
P/E compared to competitors Good
MANAGEMENT EXECUTION
Employee productivity Good
Sales growth Good
EPS growth Good
P/E growth Good
EBIT growth Good
ANALYSIS
Confident Investor Rating Good
Target stock price (TWCA growth scenario) $1175.49
Target stock price (averages with growth) $1751.67
Target stock price (averages with no growth) $648.35
Target stock price (manual assumptions) $320.41

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in this stock.

Company name GlaxoSmithKline plc (ADR)
Stock ticker GSK
Live stock price [stckqut]GSK[/stckqut]
P/E compared to competitors Good
MANAGEMENT EXECUTION
Employee productivity Good
Sales growth Poor
EPS growth Poor
P/E growth Good
EBIT growth Poor
ANALYSIS
Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $78.12
Target stock price (averages with growth) $105.32
Target stock price (averages with no growth) $51.43
Target stock price (manual assumptions) $32.44

Confident Investor comments: At this price and at this time, I do not think that a Confident Investor can confidently invest in this stock.